Description
Nubeta-H Tablet is a prescription antihypertensive medication combining Nebivolol 5 mg, a selective beta-1 adrenergic blocker, with Hydrochlorothiazide 12.5 mg, a thiazide diuretic. Manufactured by Abbott, this combination is designed to provide enhanced blood pressure control for patients who require more than monotherapy. The dual action of Nubeta-H reduces heart rate, cardiac workload, and fluid retention, effectively lowering blood pressure and reducing cardiovascular risk.
Therapeutic Uses:
-
Hypertension (High Blood Pressure):
-
Lowers elevated systolic and diastolic blood pressure.
-
Reduces the risk of stroke, heart attack, and other cardiovascular complications.
-
-
Cardiovascular Risk Management:
-
Provides synergistic action for patients not adequately controlled with a single antihypertensive agent.
-
-
Fluid Retention Management:
-
Hydrochlorothiazide promotes diuresis, reducing excess fluid and sodium retention.
-
Mechanism of Action:
-
Nebivolol (Beta-1 Blocker): Selectively blocks beta-1 adrenergic receptors in the heart, reducing heart rate, cardiac output, and myocardial oxygen demand. It also stimulates endothelial nitric oxide release, promoting vasodilation and improving arterial compliance.
-
Hydrochlorothiazide (Thiazide Diuretic): Increases renal excretion of sodium and water, reducing blood volume and peripheral vascular resistance. The diuretic effect complements Nebivolol’s cardiovascular benefits for enhanced antihypertensive efficacy.
Dosage & Administration:
-
Take Nubeta-H Tablet exactly as prescribed by a healthcare professional.
-
Typically administered once daily, at the same time each day.
-
Swallow the tablet whole with water; may be taken with or without food.
-
Regular monitoring of blood pressure, kidney function, and electrolyte levels is recommended.
-
Do not discontinue the medication abruptly.
Side Effects:
Common:
-
Dizziness or lightheadedness
-
Fatigue or headache
-
Mild gastrointestinal discomfort
-
Increased urination due to diuretic effect
Serious (rare):
-
Severe hypotension
-
Electrolyte imbalances (low potassium, sodium, or magnesium)
-
Bradycardia (slow heart rate)
-
Allergic reactions (rash, swelling, difficulty breathing)
Precautions & Warnings:
-
Prescription-only; use under medical supervision.
-
Inform your doctor if you have:
-
Severe kidney or liver impairment
-
Heart rhythm disorders (bradycardia, AV block)
-
Electrolyte imbalance
-
Diabetes or gout (Hydrochlorothiazide may alter glucose or uric acid levels)
-
-
May mask symptoms of low blood sugar in diabetic patients.
-
Not recommended in pregnancy or breastfeeding unless advised by a doctor.
Drug Interactions:
-
Other antihypertensives (may enhance hypotensive effect)
-
Antiarrhythmic drugs (risk of bradycardia or conduction abnormalities)
-
Lithium (risk of lithium toxicity with diuretics)
-
Corticosteroids or laxatives (may worsen electrolyte disturbances)
-
Alcohol (may increase hypotensive effect)
Storage:
-
Store in a cool, dry place below 25°C
-
Protect from moisture and sunlight
-
Keep out of reach of children
Key Benefits:
-
Provides dual-action blood pressure control through beta-blockade and diuresis
-
Reduces cardiac workload and heart rate
-
Promotes vasodilation and improved arterial function
-
Controls fluid retention, enhancing overall antihypertensive effect
-
Convenient once-daily dosing improves adherence
-
Manufactured by Abbott, ensuring quality, safety, and efficacy
Conclusion:
Nubeta-H Tablet, combining Nebivolol 5 mg and Hydrochlorothiazide 12.5 mg, is an effective and convenient combination therapy for hypertension. By addressing both cardiac and fluid-related components of high blood pressure, it provides comprehensive blood pressure control while reducing cardiovascular risk. Regular medical supervision, monitoring of electrolytes, and adherence to prescribed dosage are essential for optimal outcomes.
Leave a Reply